EUROAPI Appoints Frédéric Robert as Chief Commercial Officer for API Solutions and CDMO Activities

EUROAPI appoints Frédéric Robert as Chief Commercial Officer overseeing API Solutions and CDMO activities. He will lead commercial and organizational synergies, deliver the FOCUS-27 sales plan, and redefine the global sales strategy for the company. Robert has extensive experience in the pharmaceutical industry, including senior roles at Aptar, Fareva, and NAOS Bioderma. His appointment reinforces EUROAPI's position as a European leader in the API and CDMO sectors.

EUROAPI, a leading European player in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO) services, has appointed Frédéric Robert as its new Chief Commercial Officer. Robert will oversee API Solutions and CDMO activities, joining the company's Executive Committee as part of the ongoing FOCUS-27 transformation plan [1].

In his new role, Robert will be responsible for creating commercial and organizational synergies between the API Solutions and CDMO operations, delivering the FOCUS-27 sales plan, and redefining a global sales strategy for the company. He will also expand the group's presence in strategic markets and with key clients, optimizing its customer approach with integrated, high-value-added solutions [1].

"We are delighted to welcome Frédéric Robert to our team," said David Seignolle, EUROAPI Chief Executive Officer. "His extensive expertise in the pharmaceutical industry and CDMO space, along with his strategic vision for international markets, will be invaluable assets to accelerate our growth. This appointment reflects our commitment to enhancing the convergence between our API and CDMO activities to deliver even more integrated and effective solutions for our clients" [1].

Robert brings a wealth of experience in the pharmaceutical industry, having held senior leadership roles at NAOS Bioderma, Fareva, and more recently at Aptar, where he served as Vice President of EMEA Sales & Customs Development. He has led operations across Europe and North America, giving him a comprehensive understanding of the entire value chain, from API production to CDMO and CMO services [1].

This appointment comes as EUROAPI continues to expand its portfolio and presence in the global pharmaceutical market. With approximately 200 products in its portfolio and a strong focus on innovation, EUROAPI is well-positioned to meet the growing demand for high-quality API and CDMO services [1].

References:
[1] https://www.globenewswire.com/news-release/2025/06/04/3093816/0/en/Fréderic-Robert-appointed-EUROAPI-s-Chief-Commercial-Officer-overseeing-API-Solutions-and-CDMO-activities.html